Morepen Laboratories Limited Morepen Laboratories Limited

Morepen Laboratories Limited

MOREPENLAB

Rank in Stocks #11502
Morepen Laboratories Limited is an Indian pharmaceutical company primarily... Morepen Laboratories Limited is an Indian pharmaceutical company primarily engaged in the development, manufacturing, marketing, and distribution of active pharmaceutical ingredients (APIs), proprietary and generic pharmaceutical formulations, and a diverse range of home healthcare products. Its API portfolio encompasses compounds utilized in the creation of drugs for conditions such as allergies, asthma, elevated cholesterol, hypertension, and diabetes. The company also supplies an array of point-of-care and medical devices for home use, including diagnostic tools like air purifiers, thermometers, stethoscopes, blood pressure monitors, pulse oximeters, nebulizers, glucometers with accompanying strips, as well as hygiene products such as sanitizers, disinfectant solutions, masks, and gloves. Among its well-known branded products are Burnol, a cream for treating burns; Lemolate, an offering for cough and cold relief; and Fiber-X, a psyllium husk supplement. Furthermore, Morepen produces finished drug formulations covering various therapeutic areas, including gastrointestinal health, antibiotics, vitamins, nutritional support, anti-diabetics, and cardiovascular conditions. Beyond these offerings, the company undertakes contract manufacturing for other businesses and participates in brand sharing agreements. Its comprehensive range of over-the-counter (OTC) products is marketed under the recognizable Dr. Morepen brand. The company's global footprint extends to approximately 75 nations, where its products are exported. Established in 1984, Morepen Laboratories Limited maintains its headquarters in New Delhi, India.
Share Price
$0.96628714
Last synced: 2026-11-20
Market Cap
$529.91M
Change (1 day)
-0.50%
Change (1 year)
96.76%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Morepen Laboratories Limited (MOREPENLAB)

Category

Healthcare
EPS for Morepen Laboratories Limited (MOREPENLAB)
EPS as of September 2026 TTM: $0.04
According to Morepen Laboratories Limited's latest financial reports, its current EPS (TTM) is $0.04. At the end of 2025 the company had an EPS of $0.03, an increase over its 2024 EPS of $0.02.
EPS history for Morepen Laboratories Limited from 2005 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $0.04 21.33%
2025 $0.03 14.22%
2024 $0.02 139.36%
2023 $0.01 -68.46%
2022 $0.03 1.02%
2021 $0.03 195.00%
2020 $0.01 8.70%
2019 $0.01 -8.91%
2018 $0.01 23.17%
2017 $0.01 95.24%
2016 0.00 600.00%
2015 0.00 -160.00%
2014 0.00 -88.24%
2013 $-0.01 -19.05%
2012 $-0.01 -54.94%
2011 $-0.02 606.06%
2010 0.00 -85.65%
2009 $-0.02 -57.41%
2008 $-0.05 -68.82%
2007 $-0.17 239.61%
2006 $-0.05 -3.95%
2005 $-0.05 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$6.03 16,465.66%
DE
$6.01 16,404.95%
DE
$1.53 4,111.26%
JP
$3.66 9,954.95%
CH
$0.45 1,136.26%
IL

Questions about Morepen Laboratories Limited's earnings per share (EPS)

What is Morepen Laboratories Limited's earnings per share (EPS)?

Morepen Laboratories Limited's earnings per share (EPS) over the last twelve months is $0.04, as of Sep 2026.

What was Morepen Laboratories Limited's earnings per share (EPS) in 2025?

In 2025, Morepen Laboratories Limited's earnings per share (EPS) was $0.03, 50.00% more than in 2024 ($0.02).

How has Morepen Laboratories Limited's earnings per share (EPS) changed since 2020?

From 2020 to 2025, Morepen Laboratories Limited's earnings per share (EPS) went from $0.01 to $0.03, an average growth of 24.57% a year.

How does Morepen Laboratories Limited's earnings per share (EPS) compare with similar companies?

Morepen Laboratories Limited's earnings per share (EPS) ($0.04) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.03.